FDA Inspection 1077347 — Apotex Research Private Limited

Apotex Research Private Limited — FEI 3007078919

The FDA completed an inspection of Apotex Research Private Limited on Dec 7, 2018 in Bangalore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 7, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bangalore (India)

Additional Details

Bioanalytical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.